Overview

Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial

Status:
Completed

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to increase knowledge about drug properties and effects during therapeutic hypothermia. The primary end point of this study is the time from termination of sedation to extubation in patients treated with therapeutic hypothermia, after treatment with the combination remifentanil and propofol versus that of fentanyl and midazolam.

Phase:

Phase 4

Details

Lead Sponsor:

Norwegian University of Science and Technology

Collaborator:

St. Olavs Hospital

Treatments:

Fentanyl
Midazolam
Propofol
Remifentanil